Pharmacovigilance signals and regional burden of antibiotic-associated Clostridioides difficile infection: a pharmacovigilance study and Global Burden of Disease Study 2023.
- DOI
- 10.1016/j.ijantimicag.2026.108013
- Published
- 2026 Sep 22
- Container
- International journal of antimicrobial agents
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ijantimicag.2026.108013,
title = {Pharmacovigilance signals and regional burden of antibiotic-associated Clostridioides difficile infection: a pharmacovigilance study and Global Burden of Disease Study 2023.},
author = {Kim DY and Kim H and Yoo H and Shin H and Yon H and Choi T and Moon J and Kim H and López-Gil JF and Rahmati M and Woo S and Park J and Yon DK},
year = {2026},
journal = {International journal of antimicrobial agents},
doi = {10.1016/j.ijantimicag.2026.108013},
url = {https://doi.org/10.1016/j.ijantimicag.2026.108013}
}RIS
TY - JOUR TI - Pharmacovigilance signals and regional burden of antibiotic-associated Clostridioides difficile infection: a pharmacovigilance study and Global Burden of Disease Study 2023. AU - Kim DY AU - Kim H AU - Yoo H AU - Shin H AU - Yon H AU - Choi T AU - Moon J AU - Kim H AU - López-Gil JF AU - Rahmati M AU - Woo S AU - Park J AU - Yon DK PY - 2026 JO - International journal of antimicrobial agents DO - 10.1016/j.ijantimicag.2026.108013 UR - https://doi.org/10.1016/j.ijantimicag.2026.108013 ER -
APA
DY, K., H, K., H, Y., H, S., H, Y., T, C., J, M., H, K., JF, L., M, R., S, W., J, P., & DK, Y. (2026). Pharmacovigilance signals and regional burden of antibiotic-associated Clostridioides difficile infection: a pharmacovigilance study and Global Burden of Disease Study 2023.. International journal of antimicrobial agents. https://doi.org/10.1016/j.ijantimicag.2026.108013
Source records
- pubmed · retrieved 2026-09-26T02:10:12.764Z